New research suggests classical biomarkers cannot discriminate between refractory and non-refractory rheumatoid arthritis. Novel targeted therapies have made a significant impact on the treatment of ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the ...

SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today announced the completion of the first procedure in Texas using the U.S. Food and ...

Subcutaneous tocilizumab, either as monotherapy or in combination with methotrexate, demonstrated greater efficacy than methotrexate alone and was well tolerated in patients with active rheumatoid ...

Elevara Medicines has dosed the first patient in its phase 2b START-SYNERGY trial, marking a key step in the development of ...

A colleague has a 63-year-old male patient with moderate rheumatoid arthritis (RA). The patient is positive for rheumatoid factor, erythrocyte sedimentation rate is 34 mm/hr, and hand and knee x-rays ...

Rheumatoid arthritis, also known as RA, affects an estimated 1.3 million people in the United States. Beyond this staggering statistic lies a complex reality: each person's experience with RA is ...

Interleukin-6 (IL-6) is a pleiotropic cytokine that may play a role in the regulation of various aspects of the immune response, inflammation, hematopoiesis, and bone metabolism. IL-6 acts by binding ...

RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...

Patients with highly active rheumatoid arthritis (RA) experienced faster declines in kidney function than those whose disease was under better control, analysis of a large registry indicated. Compared ...

Rheumatoid Arthritis (RA) is characterized by synovial membrane hyperplasia and inflammatory cell infiltrate, including activated T cells. Once activated by one or more unidentified autoantigens, ...